TALWIN NX Detail

Drug Name(s):
TALWIN NX

FDA Application No.:
NDA 018733

Active Ingredient(s):
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE

Company:
SANOFI AVENTIS US

Original Approval or Tentative Approval Date:
December 15, 1982

Products on Application NDA 018733:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE	EQ 0.5MG BASE;EQ 50MG BASE	TABLET; ORAL	Prescription	AB

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	November 2008
S	M	T	W	T	F	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Who's online

There are currently 0 users and 451 guests online.

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

We comply with the HONcode standard for health trust worthy information:
verify here.

last updated on 11-21-2008

Links to Site

TALWIN NX Detail

Hot Topics

Sponsored Links

Recall Notices

Action Alerts

Most Recent Content

Active forum topics

Poll

Subscribe to our feed